None listed
Conditions
Brief summary
This project will assess and optimise the use of telemedicine for asthma management in children and young people across the severity range of asthma to regularly provide asthma education, provide appropriate strategies for asthma management based on the asthma management plan and reminders to take regular medication if prescribed. The use of telephone/SMS technology is highly acceptable to young people and families generally and is readily available across most patient groups.
Interventions
A pilot, formal randomised controlled trial (RCT) to examine the benefits of chronic disease monitoring 1. Interactive Voice Response (IVR) Monitoring Patients will be assigned to a category of asthma based on symptoms over the previous 12 months according to National Asthma Campaign guidelines: Episodic asthma - 60,Persistent asthma - 60. Patients will be randomised into three groups:(a) Regular care(control) group: GP/Paediatrician, hospital emergency services (b) Telemedicine (intervention) group: twice a week automated telephone calls to the family (c) Nurse support group: Telephone call by an asthma nurse every two weeks. 2. Short Message Service (SMS) Monitoring 40 adolescents with asthma will be randomised to monitoring via mobile phone using SMS (20 patients) and control group with regular care from primary physician or specialist (20 patients).
Sponsors
Study design
Eligibility
Inclusion criteria
120 children and young people with established doctor diagnosis of episodic or persistent asthma who have had at least one admission to hospital or one episode of acute care in an emergency department or paediatric clinic or general practitioner for asthma requiring steroid rescue within the previous 12 months. Suitable SMS patients will be required to have a mobile phone. Potential participants will be identified from the separation reports provided by participating hospitals.
Exclusion criteria
1. Patients with other significant respiratory or medical disorders. 2. Patients who are currently participating in other studies or drug trials.3. Families where informed consent cannot be obtained.